For instance, interventions targeting novel antidiuretic pathways (e.g., the ITPF-NK3R axis) in tumor-associated renal dysfunction could not only improve renal function but also suppress tumor progression by disrupting the kidney-brain reflex arc. The gene discussed is TACR3; the disease is neoplasm.